Biologics: Targets and Therapyhttps://www.dovepress.com/feed/journal/8New articles released by Dove Press for Biologics: Targets and Therapyen-us2026, Dove Pressangela@dovepress.com (Angela Jones)Dove Press Biologics: Targets and TherapyBiologics: Targets and Therapyhttps://www.dovepress.com/feed/journal/8https://www.dovepress.com/assets/img/addon/rss-banner.jpg140140Optimization of Recombinant Human Interferon-Gamma Expression and Purification in E. coli, and Developing an Immunization Protocol for the Production of Optimal Humoral Responsehttps://www.dovepress.com/optimization-of-recombinant-human-interferon-gamma-expression-and-puri-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyThu, 16 Apr 2026 18:55:00 +1200https://doi.org/10.2147/BTT.S584180Enhancement of Gastric Mucosal Defense by Phytomedicine in the Context of H. pylori–Associated Ulcer Diseasehttps://www.dovepress.com/enhancement-of-gastric-mucosal-defense-by-phytomedicine-in-the-context-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyTue, 14 Apr 2026 16:45:00 +1200https://doi.org/10.2147/BTT.S597797Rheumatoid Factor Beyond Rheumatoid Arthritis: A Potential Marker of Cardiometabolic and Hepatic Riskhttps://www.dovepress.com/rheumatoid-factor-beyond-rheumatoid-arthritis-a-potential-marker-of-ca-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyMon, 13 Apr 2026 23:00:00 +1200https://doi.org/10.2147/BTT.S603345Safety and Efficacy of Mesenchymal Stem Cell Therapy in Multiple System Atrophy: Systematic Reviewhttps://www.dovepress.com/safety-and-efficacy-of-mesenchymal-stem-cell-therapy-in-multiple-syste-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyTue, 31 Mar 2026 19:00:00 +1300https://doi.org/10.2147/BTT.S593367Anifrolumab in Refractory Oral Manifestations in Systemic Lupus Erythematosus: A Case Report and Literature Reviewhttps://www.dovepress.com/anifrolumab-in-refractory-oral-manifestations-in-systemic-lupus-erythe-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyMon, 16 Mar 2026 21:05:00 +1300https://doi.org/10.2147/BTT.S588071Late-Onset Ocular Myasthenia Gravis–Like Symptoms During Erenumab Therapy for Chronic Migraine: A Case Reporthttps://www.dovepress.com/late-onset-ocular-myasthenia-gravislike-symptoms-during-erenumab-thera-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyWed, 04 Mar 2026 06:10:00 +1300https://doi.org/10.2147/BTT.S579731First-Line Serplulimab versus Other Anti-PD-1/PD-L1 Antibodies Plus Chemotherapy for Esophageal Squamous Cell Carcinoma: A Systematic Review with Benefit-Risk Assessment via Matching-Adjusted Indirect Comparisonhttps://www.dovepress.com/first-line-serplulimab-versus-other-anti-pd-1pd-l1-antibodies-plus-che-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapySat, 28 Feb 2026 04:35:00 +1300https://doi.org/10.2147/BTT.S602654Network Pharmacology-Based Exploration: Non-Targeted Metabolites of Lactobacillus-Fermented Chaenomeles speciosa (Sweet) Nakai, Smilax glabra Roxb. and Pueraria montana var. Lobata in Uric Acid Metabolism Interventionhttps://www.dovepress.com/network-pharmacology-based-exploration-non-targeted-metabolites-of-lac-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyTue, 24 Feb 2026 02:55:00 +1300https://doi.org/10.2147/BTT.S578004Net Present Value Impact of FDA’s Phase 3 Waivers on Monoclonal Antibody Biosimilar Developmenthttps://www.dovepress.com/net-present-value-impact-of-fdas-phase-3-waivers-on-monoclonal-antibod-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyTue, 10 Feb 2026 19:10:00 +1300https://doi.org/10.2147/BTT.S581013Successful and Risk-Minimizing Treatment of Ulcerative Colitis by Positive Switch from JAK Inhibitors to Ustekinumabhttps://www.dovepress.com/successful-and-risk-minimizing-treatment-of-ulcerative-colitis-by-posi-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyTue, 20 Jan 2026 00:00:00 +1300https://doi.org/10.2147/BTT.S561965Research on the Role of Autophagy in Vascular Endothelial Cells in the Healing of Chronic Refractory Woundshttps://www.dovepress.com/research-on-the-role-of-autophagy-in-vascular-endothelial-cells-in-the-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyTue, 13 Jan 2026 00:00:00 +1300https://doi.org/10.2147/BTT.S573844Teclistamab for Relapsed or Refractory Multiple Myeloma: A Review of Efficacy, Safety, Resistance Mechanisms and Future Directionshttps://www.dovepress.com/teclistamab-for-relapsed-or-refractory-multiple-myeloma-a-review-of-ef-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyTue, 13 Jan 2026 00:00:00 +1300https://doi.org/10.2147/BTT.S539066Mesenchymal Stem Cell Therapy in Osteoarthritis and Rheumatoid Arthritis: A Systematic Review of Exosomal microRNAshttps://www.dovepress.com/mesenchymal-stem-cell-therapy-in-osteoarthritis-and-rheumatoid-arthrit-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyTue, 30 Dec 2025 04:20:00 +1300https://doi.org/10.2147/BTT.S571417Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing [Corrigendum]https://www.dovepress.com/corrigendum-mechanism-and-applications-of-crisprcas-9-mediated-genome--peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapySat, 27 Dec 2025 17:10:00 +1300https://doi.org/10.2147/BTT.S585961Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch: A Prospective Cohort Studyhttps://www.dovepress.com/efficacy-safety-and-cost-effectiveness-of-the-infliximab-biosimilar-gp-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyThu, 18 Dec 2025 04:50:00 +1300https://doi.org/10.2147/BTT.S559503LncRNA GAS5 Modulates the Progression of Glioma Through Repressing miR-135b-5p and Upregulating APC [Corrigendum]https://www.dovepress.com/corrigendum-lncrna-gas5-modulates-the-progression-of-glioma-through-re-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyWed, 10 Dec 2025 19:30:00 +1300https://doi.org/10.2147/BTT.S586794Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Reviewhttps://www.dovepress.com/switch-from-intravenous-to-subcutaneous-formulation-of-tocilizumab-in--peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyThu, 04 Dec 2025 14:55:00 +1300https://doi.org/10.2147/BTT.S555169Tumor-to-Tumor Metastasis: Breast Cancer Metastasizing to EGFR Exon 19-Mutated Lung Adenocarcinoma with Long-Term Disease-Free Survivalhttps://www.dovepress.com/tumor-to-tumor-metastasis-breast-cancer-metastasizing-to-egfr-exon-19--peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyWed, 19 Nov 2025 20:05:00 +1300https://doi.org/10.2147/BTT.S558828In Silico Screening of Streptomyces sp. Metabolites Targeting P. falciparum DHODH and DPCK for Antimalarial Discoveryhttps://www.dovepress.com/in-silico-screening-of-streptomyces-sp-metabolites-targeting-p-falcipa-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapySat, 15 Nov 2025 04:55:00 +1300https://doi.org/10.2147/BTT.S539147Beyond Monotherapy: Exploring the Efficacy and Safety of Dual Biologic Strategies in Rheumatic Diseaseshttps://www.dovepress.com/beyond-monotherapy-exploring-the-efficacy-and-safety-of-dual-biologic--peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapySat, 08 Nov 2025 01:50:00 +1300https://doi.org/10.2147/BTT.S565137Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0)https://www.dovepress.com/efficacy-of-belimumab-on-different-joint-and-skin-manifestations-of-sy-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyThu, 30 Oct 2025 05:30:00 +1300https://doi.org/10.2147/BTT.S536660Antibody-Based Therapeutics for Hypercholesterolemiahttps://www.dovepress.com/antibody-based-therapeutics-for-hypercholesterolemia-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyMon, 27 Oct 2025 14:45:00 +1300https://doi.org/10.2147/BTT.S500456The Dual Role of the TRAIL-DR5 Signaling Axis in Cardiovascular Disease: From Molecular Mechanisms to Targeted Therapieshttps://www.dovepress.com/the-dual-role-of-the-trail-dr5-signaling-axis-in-cardiovascular-diseas-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapySat, 25 Oct 2025 22:35:00 +1300https://doi.org/10.2147/BTT.S538522Irisin Research Landscape (2012–2024): A Bibliometric and Visual Analysis of Evolving Hotspots and Future Trendshttps://www.dovepress.com/irisin-research-landscape-20122024-a-bibliometric-and-visual-analysis--peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyWed, 22 Oct 2025 20:30:00 +1300https://doi.org/10.2147/BTT.S536800The Potential of Telitacicept in Treating Lupus erythematosus panniculitis: A Case Reporthttps://www.dovepress.com/the-potential-of-telitacicept-in-treating-lupus-erythematosus-pannicul-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyTue, 07 Oct 2025 23:50:00 +1300https://doi.org/10.2147/BTT.S551578Dual Blocking of IL17A and IL36R for the Treatment of Refractory Hidradenitis Suppurativa: A Case Reporthttps://www.dovepress.com/dual-blocking-of-il17a-and-il36r-for-the-treatment-of-refractory-hidra-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyFri, 03 Oct 2025 20:00:00 +1300https://doi.org/10.2147/BTT.S558500Migrasomes: A New Role in Disease Diagnosis and Treatmenthttps://www.dovepress.com/migrasomes-a-new-role-in-disease-diagnosis-and-treatment-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyThu, 02 Oct 2025 23:10:00 +1300https://doi.org/10.2147/BTT.S547672siRNAs, tRNAs, and rRNAs in Osteoarthritis: Biological Functions and Therapeutic Opportunitieshttps://www.dovepress.com/sirnas-trnas-and-rrnas-in-osteoarthritis-biological-functions-and-ther-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapyWed, 03 Sep 2025 22:15:00 +1200https://doi.org/10.2147/BTT.S521180Comparative Cancer Incidence by Organ Site in Rheumatoid Arthritis Treated with Janus Kinase Inhibitors versus Tumor Necrosis Factor Inhibitors: A Retrospective Real-World Cohort Analysishttps://www.dovepress.com/comparative-cancer-incidence-by-organ-site-in-rheumatoid-arthritis-tre-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapySat, 30 Aug 2025 21:00:00 +1200https://doi.org/10.2147/BTT.S532668Enhancing Early Detection of Pancreatic Cancer in Genetically Predisposed Individuals: Integrating Advanced Imaging Modalities with Emerging Biomarkers and Liquid Biopsyhttps://www.dovepress.com/enhancing-early-detection-of-pancreatic-cancer-in-genetically-predispo-peer-reviewed-fulltext-article-BTTBiologics: Targets and TherapySat, 30 Aug 2025 18:35:00 +1200https://doi.org/10.2147/BTT.S543427